Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 72485-201

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 72485-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7248520101

This single-dose vial contains 100mg of Azacitidine and 100mg of Mannitol that can be used for subcutaneous and intravenous uses only. It is important to discard any unused portion of the vial and keep it out of reach of children. It should be stored at 25°C with the excursion permitted to 15°C - 30°C. It is a cytotoxic agent that requires caution during dosing and administration. Please refer to the prescribing information for more details. This vial has a unique code TS/DRUGS/1/2013 and was manufactured by Shilpa Medicare Limited in India, whereas Armas Pharmaceuticals Inc. is responsible for its distribution in the USA.*

FDA Label Image

Graph

This appears to be a statistical output from a research study. It includes information on the significance level (p-value) of a log-rank test, hazard ratio (HR), and confidence interval (CI) for a certain variable. It also lists the number of deaths for two groups (Aza and CCR). The bottom half appears to be a survival curve showing the proportion of participants surviving over time. However, without more context, it is difficult to interpret the results or the purpose of the study.*

FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.